Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 68

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Updated Data from an Ongoing Single Arm Phase-II Investigator- Initiated Clinical Trial (PRIME Study)

Jeevan Kumar, Rajat Pincha, Vivek S Radhakrishnan, Naveed Tamboli, Arijit Nag, Dibakar Podder, Debranjani Chattopadhyay, Saurabh Jayant Bhave, Sreya Das, Mayur Parihar, Asish Rath, Sushant Vinarkar, Sumit Mukhopadhyay, Subhosmito Chakraborty, Deepak Kumar Mishra, Mammen Chandy, Reena Nair

Blood (2023) 142 (Supplement 1): 6713.

https://doi.org/10.1182/blood-2023-186903

Published: 2023

Journal Articles

Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Early Safety Data from an Ongoing Single Arm Phase-II Investigator-Initiated Clinical Trial (PRIME Study)

Vivek S Radhakrishnan, Naveed Tamboli, Shreya Das, Jeevan Kumar Garg, Arijit Nag, Saurabh J Bhave, Mayur Parihar, Sushant Vinarkar, Sumit Mukhopadhyay, Subhosmito Chakraborty, Deepak K Mishra, Reena Nair, Mammen Chandy

Blood (2021) 138 (Supplement 1): 2752.

https://doi.org/10.1182/blood-2021-151718

Published: 2021

Journal Articles

Induction Mortality in Acute Myeloid Leukemia: A 9 Year Retrospective Study from a Tertiary Care Centre in a Low-Middle Income Country Setting

Vivek S Radhakrishnan, Sandeep A Pattnaik, Arunima Bhadhuri, Vasundhara Raina, Payal Mandal, Saurabh J Bhave, Jeevan Kumar Garg, Arijit Nag, Sushant Vinarkar, Mayur Parihar, Deepak K Mishra, Reena Nair, Mammen Chandy

Blood (2021) 138 (Supplement 1): 4388.

https://doi.org/10.1182/blood-2021-154152

Published: 2021

Journal Articles

Adolescent and Young Adult Hodgkin Lymphoma: Is More Better?

Reghu K Sukumaran Nair, MDDCH DM PDF, Vivek S Radhakrishnan, MDDM MSc PDF, Avijeet K Mishra, MBBS MD, Vinay A Guntiboina, MD, Saurabh J Bhave, MDPDF, Jeevan Kumar Garg, MDDNB PDF, Indu Arun, MDPDF, Lateef Zameer, MD, Debdeep Dey, MDFRCPath, Neeraj Arora, MDPDF, Deepak K Mishra, MDPDF, Arpita Bhattacharyya, MRCP, Niharendu Ghara, MDDCH FRCPath, Rimpa B Achari, MD, Shekhar Krishnan, MRCP FRCPath PhD, Mammen Chandy, MDFRCP FRACP FRCPA, Reena Nair, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142276

Published: 2020

Journal Articles

Predictive Analysis on Prognostic Impact of Monosomy 7 in AML and Identified Therapy Options for This Cohort

Shireen Vali, PhD, Christopher R. Cogle, MD, Neeraj Arora, MD, Krishnan Shekhar, PhD, Mammen Chandy, MD, Manju Sengar, MD DM, Hasmukh Jain, MD DM, Girish Chinnaswamy, MD MRCP, Neeraj Kumar Singh, B.Tech, Shahabuddin Usmani, M.Sc., Anusha Pampana, M.Sc., Vijayashree P Shyamasundar, M.Sc., Huzaifa Sikora, B.Tech, Ansu Kumar, M.Sc., Taher Abbasi, MS, MBA, Vivek S Radhakrishnan, MDDM,MSc

Blood (2018) 132 (Supplement 1): 1539.

https://doi.org/10.1182/blood-2018-99-116603

Published: 2018

Journal Articles

Improved Outcomes with Allogeneic Stem Cell Transplantation for Aplastic Anaemia Using HLA Identical Sibling Donors: The Indian Stem Cell Transplant Registry (ISCTR) Experience

Biju George, DM, Manoranjan Mahapatra, Pravas Mishra, DM, Shashikant Apte, MD FRCPA, Sharat Damodar, MD DM, Navin Khattry, MDDM, Dharma Choudhary, MD DM, Jose Easow, MD, Revathi Raj, Tulika Seth, MD, Soniya Nityanand, MDPhD, Pankaj Malhotra, MD Additional Professor, Dinesh Bhurani, MD, Ashish Dixit, MD DM, Ajay Sharma, MD, Anupam Chakrapani, MBBS, MD DM, Sameer Ramesh Melinkeri, MD, Joseph M John, DM, Sunil Bhat, MBBS, MD FPHO, Neeraj Sidharthan, Bhausaheb Bagal, MD DM, Aby Abraham, MD DM, Ramesh Nimmagadda, T Raja, Abhijeet Ganapule, DM, V Lakshmanan, Fouzia Nambiathayil Abubacker, DM, Anu Korula, MD DM, Satyaranjan Das, Sanjeevan Sharma, Kannan Subramaniam, Rayaz Ahmed, MDDM, Narendra Agarwal, Alka Khadwal, MD, Gaurav Prakash, MBBS, MD DM, Amit Rauthan, DM, Chirag Shah, Uday Deotare, MD DM, MBBS, MNAMS, Sanjeev Kumar Sharma, MD DM, Seema S. Bhatwadekar, MD, Chandran K Nair, MD, Kavitha Lakshmi, MSc, Velu Nair, Mammen Chandy, MD, Alok Srivastava, MD FRACP, Vikram Mathews, DM

Blood (2015) 126 (23): 4386.

https://doi.org/10.1182/blood.V126.23.4386.4386

Published: 2015

Journal Articles

RNA Expression and Polymorphisms in Imatinib Influx and Efflux Transporters Influence Molecular Response to Imatinib Therapy in Newly Diagnosed Patients with Chronic Myeloid Leukemia.

Poonkuzhali Balasubramanian, Ph.D, Preetha Markose, M.Sc, Senthamizh Selvi Anandhan, M.Sc, Ramkrishna Sahu, M.Sc, Vinodhini Kumaraswamy, B.Sc, Vivi Srivastava, MD, Rayaz Ahmed, MD, Aby Abraham, MD, Biju George, MD, Mammen Chandy, MD, Alok Srivastava, MD, Vikram Mathews

Blood (2012) 120 (21): 2785.

https://doi.org/10.1182/blood.V120.21.2785.2785

Published: 2012

Journal Articles

ABC Transporter Expression in Acute Myeloid Leukemia: Association with in Vitro Cytotoxicity and Prognostic Markers

Ajay Abraham, M.Sc, Savitha Varatharajan, M.Sc, Sreeja Karathedath, M.Sc, Ashok kumar Jeyavelu, M.Sc, Shaji R Velayudhan, M.Sc, Ph.D, Rayaz Ahmed, MD, Aby Abraham, MD, Biju George, MD, Mammen Chandy, MD, Alok Srivastava, MD, Vikram Mathews, Poonkuzhali Balasubramanian, Ph.D

Blood (2012) 120 (21): 1438.

https://doi.org/10.1182/blood.V120.21.1438.1438

Published: 2012

Journal Articles

Molecular and Functional Characterization of Two Novel Missense Mutations in Iron Transport Protein Causing Hypochromic Microcytic Anemia and Hemosiderosis

Rekha Athiyarath, Neeraj Arora, MD, Rayaz Ahmed, MD, Biju George, MD, Mammen Chandy, MD, Alok Srivastava, MD, Eunice Sindhuvi Edison, Ph.D

Blood (2012) 120 (21): 3202.

https://doi.org/10.1182/blood.V120.21.3202.3202

Published: 2012

Journal Articles

Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy

Ezhilarasi Chendamarai, Poonkuzhali Balasubramanian, Biju George, Auro Viswabandya, Aby Abraham, Rayaz Ahmed, Ansu Abu Alex, Saravanan Ganesan, Kavitha M. Lakshmi, Usha Sitaram, Sukesh Chandran Nair, Mammen Chandy, Nancy Beryl Janet, Vivi M. Srivastava, Alok Srivastava, Vikram Mathews

Blood (2012) 119 (15): 3413–3419.

https://doi.org/10.1182/blood-2011-11-393264

Published: 2012

Includes: Supplemental data

Journal Articles

Carbonyl Reductase 1 Expression and Polymorphisms Influence Daunorubicin Metabolism in AML

Savitha Varatharajan, M.Sc, Ajay Abraham, M.Sc, Shaji R Velayudhan, M.Sc, Ph.D, Rayaz Ahmed, MD, Aby Abraham, MD, Biju George, MD, Mammen Chandy, MD, Alok Srivastava, MD, Vikram Mathews, MD, Poonkuzhali Balasubramanian, Ph.D

Blood (2011) 118 (21): 2484.

https://doi.org/10.1182/blood.V118.21.2484.2484

Published: 2011

Journal Articles

Expression of Ara-C Metabolizing Enzymes Mediates in Vitro Sensitivity to Ara-C in Primary AML Cells From Patients with Denovo AML,

Ajay Abraham, M.Sc, Savitha Varatharajan, M.Sc, Ashok kumar Jayavelu, M.Sc, Shaji R Velayudhan, M.Sc, Ph.D, Rayaz Ahmed, MD, Aby Abraham, MD, Biju George, MD, Mammen Chandy, MD, Alok Srivastava, MD, Vikram Mathews, MD, Poonkuzhali Balasubramanian, M.Sc., Ph.D

Blood (2011) 118 (21): 3481.

https://doi.org/10.1182/blood.V118.21.3481.3481

Published: 2011

Journal Articles

Role of Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Arsenic Trioxide in Frontline Therapy

Ezhilarasi Chendamarai, MSc, Poonkuzhali Balasubramanian, Ph.D, Biju George, MD, Kavitha M Lakshmi, MSc, Auro Viswabandhya, Aby Abraham, MD, Rayaz Ahmed, MD, Ansu Abu Alex, MSc, Saravanan Ganesan, MSc, Mammen Chandy, MD, Alok Srivastava, MD, Vikram Mathews, MD

Blood (2011) 118 (21): 941.

https://doi.org/10.1182/blood.V118.21.941.941

Published: 2011

Journal Articles

Final Analysis of a Multi-Center Randomized Controlled Trial (IAPLSG04) to Study the Optimal Duration of Arsenic Trioxide Maintenance Therapy in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia

Vikram Mathews, MD, Biju George, MD, Farah Jijina, MD, Cecil Ross, MD, Reena Nair, MD, Shashikant Apte, MD, Geetha Narayanan, MD, Atul Sharma, MD, Kavitha M Lakshmi, MSc, Auro Viswabandya, MD, Ezhilarasi Chendamarai, MSc, Poonkuzhali Balasubramanian, Ph.D, Vivi Srivastava, MD, Mammen Chandy, MD, Alok Srivastava, MD

Blood (2011) 118 (21): 426.

https://doi.org/10.1182/blood.V118.21.426.426

Published: 2011

Journal Articles

Pharmacokinetics of Cyclophosphamide Metabolites Influence Outcome in Patients with β-Thalassemia Major Undergoing Allogeneic HSCT

Poonkuzhali Balasubramanian, Salamun Desire, M.Sc, John C Panetta, PhD, Kavitha M Lakshmi, MSc, Ezhilpavai Mohanan, M.Sc, Auro Viswabandya, Biju George, MD, Vikram Mathews, MD, Mammen Chandy, MD, Alok Srivastava, MD

Blood (2011) 118 (21): 1941.

https://doi.org/10.1182/blood.V118.21.1941.1941

Published: 2011

Journal Articles

HLA-matched sibling bone marrow transplantation for β-thalassemia major

Mitchell Sabloff, Mammen Chandy, Zhiwei Wang, Brent R. Logan, Ardeshir Ghavamzadeh, Chi-Kong Li, Syed Mohammad Irfan, Christopher N. Bredeson, Morton J. Cowan, Robert Peter Gale, Gregory A. Hale, John Horan, Suradej Hongeng, Mary Eapen, Mark C. Walters

Blood (2011) 117 (5): 1745–1750.

https://doi.org/10.1182/blood-2010-09-306829

Published: 2011

Journal Articles

Allogeneic Transplant In Children with Severe Aplastic Anemia – Excellent Outcomes with the Use of a Fludarabine Based Conditioning Regimen

Biju George, MD, DM, Vikram Mathews, MD, Auro Viswabandhya, Aby Abraham, Lakshmi M Kavitha, Mammen Chandy, MD, Alok Srivastava, MD

Blood (2010) 116 (21): 3519.

https://doi.org/10.1182/blood.V116.21.3519.3519

Published: 2010

Journal Articles

Trough Level of First Dose of Busulfan (Cmin1) Is a Stronger Predictor of Graft Rejection Than Steady State Concentration (Css1) In Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Poonkuzhali Balasubramanian, Ph.D, Salamun Desire, M.Sc, Pranavi Sugumaran, M.Sc, Kavitha ML, M.Sc, Aby Abraham, MD, DM, Auro Viswabandya, MD, DM, Biju George, MD, DM, Vikram Mathews, MD, DM, Mammen Chandy, MD, Rajagopal Krishnamoorthy, D.Sc, Alok Srivastava, MD

Blood (2010) 116 (21): 518.

https://doi.org/10.1182/blood.V116.21.518.518

Published: 2010

Journal Articles

Single Agent Arsenic Trioxide Regimen for the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Initial Results of a Multicenter Randomized Controlled Study From India to Study the Optimal Duration of Arsenic Trioxide Maintenance Therapy (IAPLSG04).

Vikram Mathews, MD, Biju George, MD, Farah Jijina, MD, Cecil Ross, MD, Reena Nair, MD, Shashikant Apte, MD, Geetha Narayanan, MD, Atul Sharma, MD, Kavitha M Lakshmi, Auro Viswabandya, MD, Ezhilarasi Chendamarai, Poonkuzhali Balasubramanian, Vivi Srivastava, MD, Alok Srivastava, MD, Mammen Chandy, MD

Blood (2009) 114 (22): 2082.

https://doi.org/10.1182/blood.V114.22.2082.2082

Published: 2009

Journal Articles

Population Pharmacokinetics of Cyclophosphamide in Patients with Thalassaemia Major Undergoing HSCT Shows Body Weight, CYP450, GST and ALDH Polymorphisms as Covariates Explaining Inter-Individual Variation.

Poonkuzhali Balasubramanian, Ph.D, John Carl Panetta, Ph.D, Salamun Desire, M.Sc, Shaji R Velayudhan, Ph.D, Vikram Mathews, MD, Biju George, MD, Auro Viswabandya, Mammen Chandy, MD, Alok Srivastava, MD

Blood (2009) 114 (22): 1182.

https://doi.org/10.1182/blood.V114.22.1182.1182

Published: 2009

NARROW

Safety and Efficacy of Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Updated Data from an Ongoing Single Arm Phase-II Investigator- Initiated Clinical Trial (PRIME Study)

Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Early Safety Data from an Ongoing Single Arm Phase-II Investigator-Initiated Clinical Trial (PRIME Study)

Induction Mortality in Acute Myeloid Leukemia: A 9 Year Retrospective Study from a Tertiary Care Centre in a Low-Middle Income Country Setting

Adolescent and Young Adult Hodgkin Lymphoma: Is More Better?

Predictive Analysis on Prognostic Impact of Monosomy 7 in AML and Identified Therapy Options for This Cohort

Improved Outcomes with Allogeneic Stem Cell Transplantation for Aplastic Anaemia Using HLA Identical Sibling Donors: The Indian Stem Cell Transplant Registry (ISCTR) Experience

RNA Expression and Polymorphisms in Imatinib Influx and Efflux Transporters Influence Molecular Response to Imatinib Therapy in Newly Diagnosed Patients with Chronic Myeloid Leukemia.

ABC Transporter Expression in Acute Myeloid Leukemia: Association with in Vitro Cytotoxicity and Prognostic Markers

Molecular and Functional Characterization of Two Novel Missense Mutations in Iron Transport Protein Causing Hypochromic Microcytic Anemia and Hemosiderosis

Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy

Carbonyl Reductase 1 Expression and Polymorphisms Influence Daunorubicin Metabolism in AML

Expression of Ara-C Metabolizing Enzymes Mediates in Vitro Sensitivity to Ara-C in Primary AML Cells From Patients with Denovo AML,

Role of Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Arsenic Trioxide in Frontline Therapy

Final Analysis of a Multi-Center Randomized Controlled Trial (IAPLSG04) to Study the Optimal Duration of Arsenic Trioxide Maintenance Therapy in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia

Pharmacokinetics of Cyclophosphamide Metabolites Influence Outcome in Patients with β-Thalassemia Major Undergoing Allogeneic HSCT

HLA-matched sibling bone marrow transplantation for β-thalassemia major

Allogeneic Transplant In Children with Severe Aplastic Anemia – Excellent Outcomes with the Use of a Fludarabine Based Conditioning Regimen

Trough Level of First Dose of Busulfan (Cmin1) Is a Stronger Predictor of Graft Rejection Than Steady State Concentration (Css1) In Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Single Agent Arsenic Trioxide Regimen for the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Initial Results of a Multicenter Randomized Controlled Study From India to Study the Optimal Duration of Arsenic Trioxide Maintenance Therapy (IAPLSG04).

Population Pharmacokinetics of Cyclophosphamide in Patients with Thalassaemia Major Undergoing HSCT Shows Body Weight, CYP450, GST and ALDH Polymorphisms as Covariates Explaining Inter-Individual Variation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only